CAPTRUST Financial Advisors’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-8,682
Closed -$271K 2308
2024
Q3
$271K Buy
+8,682
New +$216K ﹤0.01% 1937
2024
Q1
Sell
-10,754
Closed -$129K 2236
2023
Q4
$129K Buy
+10,754
New +$88.1K ﹤0.01% 2494
2022
Q3
Sell
-8,663
Closed -$186K 2384
2022
Q2
$186K Buy
8,663
+1,190
+16% +$33K ﹤0.01% 1742
2022
Q1
$276K Sell
7,473
-104
-1% -$4.05K ﹤0.01% 1500
2021
Q4
$345K Sell
7,577
-104
-1% -$5.43K ﹤0.01% 1315
2021
Q3
$487K Sell
7,681
-581
-7% -$44.2K ﹤0.01% 1048
2021
Q2
$756K Buy
8,262
+7,562
+1,080% +$601K 0.01% 832
2021
Q1
$48K Buy
+700
New +$54.4K ﹤0.01% 2448

Other funds holding CDNA

CAPTRUST Financial Advisors's CDNA Position: Q4 2024 in Review

CAPTRUST Financial Advisors sold out of CareDx (CDNA) in Q4 2024, closing a stake of 8,682 shares — an estimated $271K sold.

CAPTRUST Financial Advisors first reported a position in CDNA in Q1 2021 and held it in 8 quarters. The position peaked at $756K in Q2 2021. 210 funds tracked by Wall St. Rank hold CDNA as of Q4 2024.

  • CAPTRUST Financial Advisors reported no remaining CareDx position as of Q4 2024 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 8,682 CareDx shares in Q4 2024, an estimated $271K.
  • CAPTRUST Financial Advisors first reported a position in CareDx in Q1 2021 and held it in 8 quarters.
  • CAPTRUST Financial Advisors's CareDx position peaked at $756K in Q2 2021.
  • 210 funds tracked by Wall St. Rank held CareDx as of Q4 2024.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.